Predictors of 24-month onset of macular fibrosis in type 3 macular neovascularisation.
Paolo ForteVincenzo FontanaJulia MuzioLuca Di CelloPaolo CorazzaRaffaella RosaDonatella MusettiAldo VaggeCarlo Enrico TraversoMassimo NicolòPublished in: The British journal of ophthalmology (2024)
Our study identifies SHRM and multilaminae as relevant predictors of 24-month onset of MF in patients with T3 MNV. These findings enrich our understanding of the development of MF in T3 MNV and can guide improved risk prognostication. Future research should consider larger samples and prospective designs to validate these predictors.